OmniAb IncNASDAQ:OABI
- LAST PRICE3.9200
- TODAY'S CHANGE (%)-0.2300 (-5.5422%)
- Bid / Lots3.9100/ 10
- Ask / Lots3.9200/ 11
- Open / Previous Close4.1500 / 4.1500
- Day Range
- 52 Week Range
- Volume177,211
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | OABI |
|---|---|---|
| 09:32 ET | 3449 | 4.16 |
| 09:35 ET | 1700 | 4.17 |
| 09:37 ET | 900 | 4.18 |
| 09:39 ET | 900 | 4.2 |
| 09:42 ET | 200 | 4.19 |
| 09:44 ET | 200 | 4.185 |
| 09:46 ET | 2306 | 4.2 |
| 09:48 ET | 5201 | 4.2 |
| 09:50 ET | 2915 | 4.19 |
| 09:51 ET | 2355 | 4.17 |
| 09:53 ET | 2231 | 4.17 |
| 09:55 ET | 300 | 4.17 |
| 10:00 ET | 200 | 4.17 |
| 10:02 ET | 7400 | 4.17 |
| 10:04 ET | 1436 | 4.175 |
| 10:06 ET | 2300 | 4.175 |
| 10:08 ET | 19576 | 4.125 |
| 10:09 ET | 4374 | 4.065 |
| 10:11 ET | 8315 | 4.04 |
| 10:13 ET | 300 | 4.03 |
| 10:15 ET | 400 | 4.0325 |
| 10:18 ET | 2580 | 4.01 |
| 10:20 ET | 2890 | 4.02 |
| 10:22 ET | 800 | 4.03 |
| 10:26 ET | 1473 | 4.025 |
| 10:27 ET | 200 | 4.015 |
| 10:29 ET | 400 | 4.01 |
| 10:31 ET | 4872 | 3.986 |
| 10:33 ET | 2005 | 3.975 |
| 10:38 ET | 3411 | 3.975 |
| 10:40 ET | 3335 | 3.995 |
| 10:42 ET | 4372 | 4 |
| 10:44 ET | 1583 | 3.995 |
| 10:45 ET | 3432 | 3.995 |
| 10:47 ET | 300 | 3.98 |
| 10:49 ET | 100 | 3.98 |
| 10:51 ET | 2800 | 3.99 |
| 10:54 ET | 700 | 3.98 |
| 10:56 ET | 600 | 3.99 |
| 10:58 ET | 100 | 3.99 |
| 11:02 ET | 1278 | 3.985 |
| 11:03 ET | 600 | 3.985 |
| 11:05 ET | 977 | 3.975 |
| 11:07 ET | 1895 | 3.955 |
| 11:09 ET | 700 | 3.955 |
| 11:12 ET | 921 | 3.945 |
| 11:14 ET | 547 | 3.93 |
| 11:16 ET | 1767 | 3.935 |
| 11:18 ET | 100 | 3.93 |
| 11:20 ET | 100 | 3.93 |
| 11:21 ET | 4475 | 3.94 |
| 11:23 ET | 300 | 3.93 |
| 11:25 ET | 200 | 3.93 |
| 11:27 ET | 318 | 3.93 |
| 11:30 ET | 800 | 3.935 |
| 11:32 ET | 200 | 3.93 |
| 11:36 ET | 500 | 3.925 |
| 11:38 ET | 400 | 3.92 |
| 11:39 ET | 3929 | 3.915 |
| 11:41 ET | 2625 | 3.915 |
| 11:45 ET | 1978 | 3.9 |
| 11:48 ET | 300 | 3.9 |
| 11:50 ET | 300 | 3.9 |
| 11:52 ET | 600 | 3.9 |
| 11:54 ET | 603 | 3.904 |
| 11:56 ET | 4329 | 3.92 |
| 11:57 ET | 300 | 3.93 |
| 11:59 ET | 326 | 3.925 |
| 12:01 ET | 200 | 3.93 |
| 12:03 ET | 530 | 3.925 |
| 12:06 ET | 621 | 3.92 |
Nov 14, 2024
DJ OmniAb Price Target Maintained With a $8.00/Share by Benchmark, from 9:43AM ET on Thursday Nov 14, 2024 by Dow Jones
9:43AM ET on Thursday Nov 14, 2024 by Dow JonesDJ OmniAb Price Target Maintained With a $11.00/Share by HC Wainwright & Co., from 6:04AM ET on Thursday Nov 14, 2024 by Dow Jones
6:04AM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 13, 2024
DJ OmniAb Down Over 9%, on Pace for Largest Percent Decrease Since November 2022 -- Data Talk, from 2:24PM ET on Wednesday Nov 13, 2024 by Dow Jones
2:24PM ET on Wednesday Nov 13, 2024 by Dow Jones
Nov 12, 2024
OmniAb Reports Third Quarter 2024 Financial Results and Business Highlights, from 4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
4:05PM ET on Tuesday Nov 12, 2024 by Dow JonesPress Release: OmniAb Reports Third Quarter 2024 Financial Results and Business Highlights, from 4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
OmniAb Inc | 471.3M | -6.3x | --- |
Foghorn Therapeutics Inc. | 435.9M | -4.0x | --- |
Cartesian Therapeutics Inc | 479.6M | -0.5x | --- |
Tango Therapeutics Inc | 421.1M | -3.3x | --- |
Silence Therapeutics PLC | 327.1M | -6.2x | --- |
Silence Therapeutics PLC | 327.1M | -5.0x | --- |
Company Information
OmniAb, Inc. offers a discovery platform that provides pharmaceutical industry partners with access to diverse antibody repertoires and high-throughput screening technologies to enable the discovery of next-generation therapeutics. The OmniAb platform is the biological intelligence (BI) of transgenic animals, including OmniRat, OmniChicken, and OmniMouse, which have been genetically modified to generate antibodies with human sequences to facilitate the development of human therapeutic candidates. The Company’s OmniFlic (transgenic rat) and OmniClic (transgenic chicken) address industry needs for bispecific antibody applications through a common light chain approach, and OmniTaur features structural attributes of cow antibodies for complex targets. The Company's OmniChicken and OmniClic offer affinity-matured antibodies in an evolutionarily distant chicken host environment, which can deliver a diverse repertoire of antibody panels to conserved therapeutic target antigens.
Contact Information
- Headquarters
- 5980 Horton Street, Suite 600EMERYVILLE, CA, United States 94608
- Phone
- 510-250-7800
- Fax
- 302-636-5454
Executives
- Chairman of the Board
- John Higgins
- President, Chief Executive Officer, Director
- Matthew Foehr
- Executive Vice President - Finance, Chief Financial Officer
- Kurt Gustafson
- Chief Legal Officer, Secretary
- Charles Berkman
- Independent Director
- Carolyn Bertozzi
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $471.3M |
|---|---|
Revenue (TTM) | $20.4M |
Shares Outstanding | 120.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.62 |
Book Value | $2.69 |
P/E Ratio | -6.3x |
Price/Sales (TTM) | 23.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -391.14% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
